US 10822588
Agents and methods to elicit anti-tumor immune response
granted A61KA61K2039/57A61K2239/38
Quick answer
US patent 10822588 (Agents and methods to elicit anti-tumor immune response) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K2039/57, A61K2239/38, A61K40/11, A61K40/42